Savara Inc

NASDAQ:SVRA  
4.81
+0.02 (+0.42%)
4:03:57 PM EDT: $4.81 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Savara Inc Stock, NASDAQ:SVRA

1717 Langhorne Newtown Road, Suite 302, Langhorne, Pennsylvania 19047
United States of America
Phone: +1.512.614.1848
Number of Employees: 37
http://www.savarapharma.com

Description

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.